Cargando…
Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis
BACKGROUND: Carcinoma of the esophagus is an aggressive malignancy with an increasing incidence. Its virulence, in terms of symptoms and mortality, justifies a continued search for optimal therapy. The large and growing number of patients affected, the high mortality rates, the worldwide geographic...
Autores principales: | Malthaner, Richard A, Wong, Rebecca KS, Rumble, R Bryan, Zuraw, Lisa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC529457/ https://www.ncbi.nlm.nih.gov/pubmed/15447788 http://dx.doi.org/10.1186/1741-7015-2-35 |
Ejemplares similares
-
Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline
por: Malthaner, Richard A, et al.
Publicado: (2004) -
The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: a practice guideline
por: Figueredo, Alvaro, et al.
Publicado: (2003) -
Neoadjuvant and adjuvant therapy in esophageal cancer
por: Weiss, Jennifer A., et al.
Publicado: (2023) -
The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT): Randomized parallel clinical superiority trial
por: Malthaner, Richard A., et al.
Publicado: (2022) -
Evaluation of neoadjuvant immunotherapy and traditional neoadjuvant therapy for resectable esophageal cancer: a systematic review and single-arm and network meta-analysis
por: Wang, Hesong, et al.
Publicado: (2023)